Presence of rash associated with improved survival in patients receiving adjuvant Erbitux® for locally advanced head and neck cancer
Source: professional.cancerconsultants.com Author: staff A multicenter randomized trial has shown that patients with locoregionally advanced head and neck cancer receiving adjuvant [...]